NFCR Celebrates CEO Dr. Sujuan Ba’s Recognition on OncoDaily’s 100 Most Influential CEOs in Oncology for 2025
Sujuan Ba/LinkedIn

NFCR Celebrates CEO Dr. Sujuan Ba’s Recognition on OncoDaily’s 100 Most Influential CEOs in Oncology for 2025

National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:

“We are proud to recognize our CEO, Dr. Sujuan Ba, for being named to OncoDaily’s 100 Most Influential CEOs in Oncology for 2025 – an honor recognizing leaders whose work is shaping the future of global cancer research.

Dr. Ba is recognized for her leadership in positioning NFCR as a strategic accelerator of cancer research, advancing scientific innovation, fostering cross-sector collaboration, and addressing systemic challenges across the research ecosystem.

This recognition reflects not only her leadership, but the collective impact of the researchers, partners, and advocates working every day to move science forward and put patients first.”

Sujuan Ba

Sujuan Ba Recognized Among The 100 Most Influential CEOs in Oncology in 2025

Sujuan Ba